Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica

Page 1 of about 1 results

ea0056p754 | Neuroendocrinology | ECE2018

Initiation of tolvaptan therapy for mild/moderate chronic SIADH-induced hyponatremia in a day-ward

Ramos Elvira , Barrio Elvira , Miguel Paz de , Cuesta Martin , Fernandez Luzdivina , Victoria Saez de Parayuelo Maria , Maria Cruz Anba , Ortiz Marta , Calle Alfonso , Runkle Isabelle

Introduction: Tolvaptan is the only V2-receptor antagonist authorized for use in Europe in patients with SIADH. Its initiation requires hospitalization. Our goal was to analyze the safety and efficacy of tolvaptan started in a Hospital Day-Ward.Material and methods: Retrospective descriptive study of 33 ambulatory patients with mild/moderate SIADH-induced chronic sustained hyponatremia initiating tolvaptan therapy in the Day-Ward of a tertiary center ove...
0 shares

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more